Term ends Jan 3, 2032 · High confidence
Held by Boston Scientific Scimed, Inc.
Filed Jun 22, 2015 as application 29/530,998 · Granted Jan 3, 2017
Base term, 15 years from grant
Today
2017
2032
Clock starts
Jan 3, 2017
Jan 3, 2017
Term ends
Jan 3, 2032
Jan 3, 2032
base term
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
15 years from grant
Base term
No maintenance fees are payable on this kind of patent.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its base term, 15 years from grant, with no adjustment for prosecution delay. No maintenance fees are payable on this kind of patent. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 15 years from grant | Granted Jan 3, 2017 | Jan 3, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Computed term end | The steps above, in order | Jan 3, 2032 | High confidence |
This family
| US 8,944,990 | In force Sep 2032 | Sep 2032 |
| US 10,357,284 | In force no later than Oct 2029 | no later than Oct 2029 |
| US D733,298 | In force Jun 2029 | Jun 2029 |
| US D775,729 | this patent Jan 2032 | Jan 2032 |
| US 10,398,431 | In force Aug 2030 | Aug 2030 |
| US 12,310,623 | In force May 2031 | May 2031 |
| Application 19/016,750 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 15, 2015 Reel 37300, frame 199 | AMS Research Corpation | AMS Research, LLC | Change of Name |
| Jan 11, 2016 Reel 37473, frame 745 | AMS Research, LLC | Aphrodite Women's Health, LLC | Assignment of Assignor's Interest |
| Jan 11, 2016 Reel 37473, frame 919 | Aphrodite Women's Health, LLC | Astora Women's Health, LLC | Change of Name |
| Feb 25, 2016 Reel 37916, frame 28 | AMS Research Corporation | AMS Research, LLC | Corrective Assignment to Correct the Conveying Party Data; Previously Recorded on Reel 037300 Frame 0199. Assignor(S) Hereby Confirms the Change of Name. |
| Sep 13, 2016 Reel 39720, frame 182 | Mujwid, James R; Otte, John F | AMS Research Corporation | Assignment of Assignor's Interest |
| Jun 8, 2017 Reel 42743, frame 278 | Astora Women's Health, LLC | Wilmington Trust, National Association, as Collateral Trustee | Security Interest |
| Sep 7, 2017 Reel 43777, frame 895 | Astora Women's Health, LLC; Endo Health Solutions Inc.; Astora Women's Health Holdings, LLC | Boston Scientific Corporation | Assignment of Assignor's Interest |
| Sep 7, 2017 Reel 43778, frame 167 | Boston Scientific Corporation | Boston Scientific Scimed, Inc. | Assignment of Assignor's Interest |
| Apr 26, 2024 Reel 67240, frame 1 | Wilmington Trust, National Association | Actient Pharmaceuticals LLC; Astora Women’s Health Holdings, LLC; Astora Women’s Health LLC; Auxilium Pharmaceuticals, LLC; Auxilium US Holdings, LLC; BioSpecifics Technologies Corp.; BioSpecifics Technologies LLC; Dava International, LLC; Dava Pharmaceuticals, LLC; Endo Generic Holdings, Inc. (Formerly Known as Par Pharmaceuticals Companies, Inc.); Endo Pharmaceuticals Inc.; Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.); Generics Bidco I, LLC; Generics International (US), Inc.; Par Pharmaceutical, Inc.; Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC); Quartz Specialty Pharmaceuticals, LLC; Slate Pharmaceuticals, LLC; Vintage Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Actient Pharmaceuticals LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health Holdings, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium US Holdings, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies Corp. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava International, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Generic Holdings, Inc. (Formerly Known as Par Pharmaceuticals Companies, Inc.) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics Bidco I, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics International (US), Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Pharmaceutical, Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Quartz Specialty Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Slate Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Vintage Pharmaceuticals, LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center
No maintenance fees are payable on this kind of patent, so the record carries no fee events.
What's changing
Jan 2032
Term ends Jan 3, 2032. No maintenance fees are payable on this kind of patent
Citations
11
later US patents cite this one
That is below the median of design patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.